Opportunities for European pharmaceutical and biotechnology companies in Indian and Chinese markets

Despite having over a third of the world's population, Asia accounts for only one fifth of global pharmaceutical drug consumption. As income levels rise, demand from this large population base is set to burgeon, opening up new growth opportunities for pharmaceutical and biotechnology companies. Even as emerging markets such as Brazil, Mexico, Poland and Russia exhibit strong development potential, the most exciting growth prospects are forecast for two Asian powerhouses - India and China
read more: http://healthcare.frost.com

Comments

Popular posts from this blog

The Council of the European Union has decided that the European Medicines Agency (EMA) will be relocated to the City of Amsterdam.

Inflamation and Alzheimer disease

spondyloarthritis (SpA), Diclofenac and Myocardial Infarction